A joint venture in Nevada between two mining giants – creating the single-largest gold producing operation in the world (and one with the potential to become what the author of today’s article refers to as “the ‘Walmart’ of the mining world”) – could be a major sign that gold miners are anticipating a bull run in gold prices. And with gold mining stocks still greatly undervalued relative to the market, now may be the time to consider investing in gold miners. For more, CLICK HERE.
Thank the Fed’s new-found dovishness towards rate hikes (among other factors): After housing stocks experienced their worst year in a decade in 2018, today’s article notes that “homebuilders have executed a spectacular recovery this year” and “are likely to snap up substantial gains”. For five specific homebuilder stocks that have posted significant gains so far this year – and which appear poised for even more – CLICK HERE.
It was once the king of the U.S. automakers – until it was pummeled and ended up filing for Chapter 11 bankruptcy. We’re talking about General Motors – and today’s article notes that, after its reorganization, “Any money invested in the new GM at the time of its IPO has doubled, counting dividends and stock appreciation.” So is now a good time to invest in GM for the long term? The author identifies the factors affecting the auto industry that are relevant to making this determination – and examines how GM is positioned in regards to each. For more, CLICK HERE.
“You’re going to need a telescope to see copper prices in 2021,” declares one major player in the mining industry cited in today’s article. One major reason behind the phenomenal growth expected for copper demand – and copper prices – in the coming years? The trend towards “copper-gobbling” renewable energy, the corporate purchasing of which more than doubled from 2017 to 2018. And then there’s the trend towards copper-gobbling electric vehicles, most notably in China. For more on why 2019 could be a crowning year for copper (and copper miners) – and some specific copper miners to consider for exposure – CLICK HERE.
If emerging markets are not already a core part of your portfolio, you may be missing out on what one analyst declares will be “the global growth powerhouse over the next 10 years” – not the developed economies of the U.S. or Europe, but rather the likes of Vietnam, Indonesia and others. For more on why “emerging markets have to be a core part of your portfolio” – and the risks that accompany the opportunities that emerging markets present, CLICK HERE.
How did a self-made Brazilian billionaire lose his $35 billion empire practically overnight? The author of today’s article points to a lesson that he advises investors need to be aware of: “The portfolio that helps you get rich isn’t necessarily the portfolio that’s going to help you remain rich.” So, if you’re an investor that has amassed significant wealth, how can you go about engineering a portfolio that will help you keep (and ideally continue to grow) that wealth? The author shows why this is more difficult than many think – and outlines what may be the best strategy. CLICK HERE.
While the revolution from traditional retail to online retail has been underway for quite some time in developed markets, emerging markets are now seeing significant increases in e-commerce sales – and there’s a new ETF available to investors looking to tap into this momentum. For more on this ETF, which has an exclusive focus on international online retailing and which today’s article declares “should see uninterrupted success”, CLICK HERE.
“New traders are often seduced by the patterns of indicators, but this work invariably ends in disappointment when results don’t follow,” notes the author of today’s article. Given this, he proceeds to outline what may be a better approach to getting started in technical analysis. For this approach (the principles of which even more experienced traders can still benefit from) and some of the “pitfalls” of traditional technical analysis, CLICK HERE.
Gossamer Bio is a San Diego-based biotech that is readying for an initial public offering – and with a diverse pipeline including potential treatments for a severe type of asthma, pulmonary arterial hypertension and inflammatory bowel disease, this IPO could be particularly appealing to investors. However, despite the promise associated with this biotech, there are also a number of potential problems that prospective investors should be aware of. For more, CLICK HERE.
After experiencing a rough 2018, today’s article notes that “the investment case for emerging markets has vastly improved” – and highlights some specific emerging market recommendations from some big-name investors. Among these recommendations is an Eastern European bank which one equity research firm notes “ranks first as the most undervalued name with outstanding profitability… and one of the highest dividend yields in the sector”. For more, CLICK HERE.